AGEN

Agenus News

Kaufen
Verkaufen
Name Symbol Markt Aktientyp
Agenus Inc AGEN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,05 -1,89% 2,60 01:53:49
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,61 2,57 2,665 2,57 2,65
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.2.202322:29EDGARAmended Statement of Ownership (sc 13g/a)
01.2.202322:31EDGARStatement of Ownership (sc 13g)
26.1.202313:30GLOBEAgenus to Participate in February Investor Conferences
23.1.202313:30GLOBEAgenus Presents Clinical Data Demonstrating Durable..
10.1.202314:30GLOBEAgenus to Participate at B Riley Securities’ 2023 Virtual..
10.1.202300:04EDGARStatement of Changes in Beneficial Ownership (4)
09.1.202323:49EDGARStatement of Changes in Beneficial Ownership (4)
09.1.202323:43EDGARStatement of Changes in Beneficial Ownership (4)
04.1.202317:26EDGARStatement of Changes in Beneficial Ownership (4)
04.1.202317:21EDGARStatement of Changes in Beneficial Ownership (4)
04.1.202317:16EDGARStatement of Changes in Beneficial Ownership (4)
23.12.202222:16EDGARCurrent Report Filing (8-k)
23.12.202222:08EDGARAutomatic Shelf Registration Statement of Securities of..
21.12.202214:30GLOBEAgenus to Present Botensilimab Data at Late-Breaking Oral..
02.12.202222:14EDGARCurrent Report Filing (8-k)
17.11.202214:30GLOBEAgenus Data at CTOS 2022 Highlight Durable Clinical..
16.11.202214:30GLOBEAgenus to Participate at 5th Annual Evercore ISI HealthCONx..
14.11.202214:30GLOBEAgenus Data at SITC 2022 Highlight Durable Responses of..
08.11.202214:01EDGARCurrent Report Filing (8-k)
08.11.202214:00GLOBEAgenus Provides Corporate Update and Third Quarter 2022..
25.10.202214:30GLOBEAgenus to Provide Corporate Update and Third Quarter 2022..
13.10.202214:32GLOBEGSK’s older adult RSV vaccine candidate, containing Agenus’..
12.10.202214:00GLOBEVBI Vaccines and Agenus Announce Collaboration to Evaluate..
05.10.202219:11EDGARStatement of Changes in Beneficial Ownership (4)
05.10.202219:08EDGARStatement of Changes in Beneficial Ownership (4)
05.10.202214:30GLOBEAgenus to Host “The Road Taken” R&D Event on November 12,..
05.10.202214:00GLOBEAgenus to Present Botensilimab Data at a Plenary Session of..
12.9.202214:30GLOBEAgenus Makes Senior Regulatory and Clinical Appointments
11.8.202222:40EDGARSecurities Registration: Employee Benefit Plan (s-8)
09.8.202219:05TRMNB.Riley Financial Remains a Buy on Agenus (AGEN)
09.8.202214:00GLOBEAgenus Provides Corporate Update and Second Quarter 2022..
09.8.202213:57EDGARQuarterly Report (10-q)
05.8.202222:16EDGARCurrent Report Filing (8-k)
02.8.202214:30GLOBEAgenus to Participate at BTIG Biotechnology Conference
01.8.202214:30GLOBEAgenus Announces First Patient Dosed in Phase 1 Study of..
27.7.202214:30GLOBEAgenus to Provide Corporate Update and Second Quarter 2022..
06.7.202221:53EDGARStatement of Changes in Beneficial Ownership (4)
06.7.202221:52EDGARStatement of Changes in Beneficial Ownership (4)
06.7.202221:52EDGARStatement of Changes in Beneficial Ownership (4)
06.7.202221:50EDGARStatement of Changes in Beneficial Ownership (4)
02.7.202215:15TRMNWilliam Blair Thinks Agenus’ Stock is Going to Recover
30.6.202214:30GLOBEAgenus to Participate at William Blair’s Biotech Focus..
29.6.202213:00GLOBEAgenus Shows Unprecedented Activity for..
21.6.202214:30GLOBEAgenus to Host Investor Webcast to Review Late-Breaking..
14.6.202222:07EDGARCurrent Report Filing (8-k)
10.6.202217:15TRMNB.Riley Financial Thinks Agenus’ Stock is Going to Recover
10.6.202214:00GLOBEGSK’s RSV vaccine candidate for older adults, containing..
09.6.202222:06EDGARProxy Statement - Notice of Shareholders Meeting..
31.5.202214:30GLOBEAgenus Advances Portfolio with 6 Clinical Collaborations
25.5.202214:30GLOBEAgenus to Participate at Jefferies Healthcare Conference
Kürzlich von Ihnen besucht
NASDAQ
AGEN
Agenus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Melden Sie sich bei ADVFN an
Jetzt registrieren

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20230204 12:25:17